I didn't want to post this but do you think they wanted the efficacy to appear to be the problem so they could hide some embarassing problems with mfg? The scenario would be, "sure they mentioned some mfg problems that we can fix but did you see how bad our efficacy case was? No one would approve this so selling my shares was based on public info..."
This isn't trivial and a few problems would have been expected but when you see things like the cd54 results and hear things like "governance issues" you have to wonder about these guys.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.